Vitiligo is a common pigmentary disorder with a potential link to metabolic syndrome (MS).This study investigates the prevalence and clinical implications of MS among vitiligo patients. A case-control study was conducted atPost graduate department of Dermatology, Venereology & Leprosy, SMGS Hospital, Government Medical College, Jammu from November 2019 to October 2020 after obtaining approval from institutional ethical committee. This study involving 60 vitiligo patients and 60 matched controls. Key parameters such as lipid profile, fasting blood sugar, blood pressure, and abdominal circumference were assessed. Statistical analysis revealed significant variations in HDL, triglyceride levels, and fasting blood sugar between the groups. The prevalence of MS in vitiligo patients was 18.3%, with increased severity correlating with metabolic risk factors. These findings suggest that early screening and management are crucial for vitiligo patients with metabolic disturbances.